N. Machado, Juliana Tedesco Dias, Gabriela Nascimento Hercos, Thabata Koester Weber, Mary de Assis Carvalho
{"title":"Pediatric Functional Constipation in Clinical Practice: The Continuous Search for the Light at the End of the Tunnel","authors":"N. Machado, Juliana Tedesco Dias, Gabriela Nascimento Hercos, Thabata Koester Weber, Mary de Assis Carvalho","doi":"10.33696/gastroenterology.4.047","DOIUrl":"https://doi.org/10.33696/gastroenterology.4.047","url":null,"abstract":"Functional constipation (FC) has a pooled world prevalence of 9.5%, a clear definition by Rome IV Criteria, and the NAPGHAN/ESPGHAN guidelines recommendation for management. With well-defined parameters, this commentary discusses the paths followed by the literature to implement different therapeutic modalities over time. The text will prioritize information based on systematic reviews, meta-analyses, or reviews. Recently, an Editorial exploring gastrointestinal diseases across the Lifespan linked constipation as a “vexing issue that, unfortunately, has the potential to impair Health-Related Quality of Life (HRQOL).” Indeed, The Rome Foundation recommended that HRQOL scores may assist in diagnosis, management, prognosis, and therapeutic decisions. Therefore, it can be helpful for clinicians, psychologists, and researchers and could be used to support health services that want to implement an HRQOL program. The final idea is to propose HRQOL as a secondary outcome for Pediatric FC monitoring this disorder.","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"57 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138945833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luis Fonte Galindo, Yamilé Aleaga Santiesteban, María Ginori Gilke, Yosiel Molina, Yisel Hernández Barrios
{"title":"Blastocystosis and Urticaria: An Overview from a Syndemic Perspective","authors":"Luis Fonte Galindo, Yamilé Aleaga Santiesteban, María Ginori Gilke, Yosiel Molina, Yisel Hernández Barrios","doi":"10.33696/gastroenterology.4.046","DOIUrl":"https://doi.org/10.33696/gastroenterology.4.046","url":null,"abstract":"Numerous studies have found an association between infection by some species of intestinal parasites and the development of urticarial lesions. In this document we have commented on the published findings that show the association between infection by Blastocystis spp. and urticaria, and on the theorizations in relation to the mechanisms that would explain it.\u0000\u0000Due to sharing risk factors and transmission ways, there is a marked geographic coincidence among intestinal parasitic infections. In fact, polyparasitism is a common phenomenon in low- and middle-income countries in Sub-Saharan Africa, Asia, Latin America, and the Caribbean where infections by protozoa and intestinal helminths are endemic. This argument, among others, suggest that the epidemiological and healthcare approach to urticaria associated with infection by Blastocystis spp. should be done from a syndemic approach that takes into account the ways in which social environments contribute to intestinal parasite infections clustering, the pathways through which those infections could interact biologically in each individual influencing the development and evolution of urticarial lesions, and the ways in which those interactions complicate diagnosis and treatment.","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"33 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138945850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advancements in Drug Delivery Systems for Natural Compounds Targeting Metabolic Disorders Associated with Inflammation","authors":"Roberto Sam, Sel Neal","doi":"10.33696/gastroenterology.4.045","DOIUrl":"https://doi.org/10.33696/gastroenterology.4.045","url":null,"abstract":"The global incidence of metabolic disorders is on the rise, posing a significant challenge to public health. With remarkable advancements in diagnostic tools and clinical procedures, our understanding of the etiology and underlying pathophysiology of these disorders has expanded considerably. Furthermore, the utilization of in vitro and in vivo experimental models, preceding clinical investigations, has catalyzed numerous breakthroughs in biomedicine, particularly in the identification and development of potential drug candidates for the management of metabolic disorders. Natural compounds isolated from various sources have garnered extensive attention as prospective drug candidates for the treatment of conditions such as diabetes, obesity, heart-related diseases, and cancer. This interest is partly attributed to their inherent antioxidant and anti-inflammatory properties. Concurrently, intensive research efforts have been directed towards enhancing the bioactivity and bioavailability of these compounds through selected drug delivery strategies. In this article, we provide valuable insights into recent advancements that shed light on the role of inflammatory-mediated responses in the initiation of metabolic disorders, with a specific focus on conditions like diabetes mellitus, obesity, heart-related diseases, cancer, and related drug delivery systems. Additionally, we explore the promising potential of natural products in managing these metabolic disorders. Furthermore, we present lists of potential biological targets suitable for high throughput screening in the drug discovery and development process. Finally, we delve into the findings gleaned from preclinical and clinical studies, setting the stage for the identification of suitable approaches in the realm of phytochemical drug delivery systems that hold promise for the treatment of metabolic disorders.","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"15 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138607119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
O. Hernández, Zoilo K Suarez, Talwinder K Nagi, M. A. Haider, Charles Vallejo, Fatima Ahson
{"title":"Exploring the Use of Point of Care Ultrasound in Screening for Non-Alcoholic Fatty Liver Disease: A Systematic Literature Review and Meta-Analysis","authors":"O. Hernández, Zoilo K Suarez, Talwinder K Nagi, M. A. Haider, Charles Vallejo, Fatima Ahson","doi":"10.33696/gastroenterology.4.042","DOIUrl":"https://doi.org/10.33696/gastroenterology.4.042","url":null,"abstract":"Non-alcoholic fatty liver disease (NAFLD) is a major cause of cirrhosis and liver failure globally. Despite its broad impact, screening recommendations for NAFLD remain varied based between gastrointestinal societies. Point of care ultrasound (POCUS) has emerged as a new form of screening and diagnosing intrabdominal pathologies including NAFLD. We aimed to estimate the effectiveness of POCUS in screening for NAFLD compared to formal ultrasound when screening by general practitioners trained in ultrasonography. Data was collected from Cochrane, PubMed, Embase, and Google Scholar using search terms related to POCUS and NAFLD screening. Observational cross-sectional studies were included in our analysis. Reviewers evaluated articles for eligibility and extracted data for analysis. The risk of bias was assessed by reviewers using a validated risk of bias assessment tool. Discrepancies between authors were resolved by a third reviewer or by consensus. Our review found 3 studies (n = 428) that met our eligibility criteria. Our review found that POCUS was 93% sensitive and 98% specific when screening for NAFLD compared to formal ultrasound. We concluded that POCUS is an acceptable method of screening for NAFLD when used by general practitioners trained in ultrasonography. Further, more robust, studies are required to validate the findings of our review and elucidate further horizons on this emerging screening method.","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89681870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neurofibromatosis Type 1 and Crohn’s Disease Association: Case Report","authors":"A. AlShahrabally, D. Coghlan, S. Quinn","doi":"10.33696/gastroenterology.4.041","DOIUrl":"https://doi.org/10.33696/gastroenterology.4.041","url":null,"abstract":"We described a 15-year-old- a boy who presented with neurofibromatosis type 1 and Crohn’s disease. Neurofibromatosis 1 (NF1) is the most common form of NF, affecting 1 in 3000 individuals. Crohn’s disease is one of the inflammatory bowel diseases. Its incidence is significantly rising in Ireland. Concomitant association of NF1 and Crohn’s disease is a rare finding. This is the first case reported in the paediatric population.","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"401 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76529771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vishnu P. Tripathi, H. Ahmed, Naidia Renulos, M. K. Aneebuddin
{"title":"Elucidating the Role of Chemokines in Infectious Diseases and Gastric Cancer","authors":"Vishnu P. Tripathi, H. Ahmed, Naidia Renulos, M. K. Aneebuddin","doi":"10.33696/gastroenterology.3.039","DOIUrl":"https://doi.org/10.33696/gastroenterology.3.039","url":null,"abstract":"Vishnu P. Tripathi1, Haamza Ahmed2, Naidia Renulos3, M K Aneebuddin4 1Department of Biotechnology, V.B.S. Purvanchal University, Jaunpur, India 2Department of Biomedical Engineering, University of Memphis, USA 3Department of infectious biology, University of Verona, Italy 4Department of Pharmaceutics, Shadan College of Pharmacy, Telangana State, India *Correspondence should be addressed to Vishnu P. Tripathi, tripatipvishnu@gmail.com","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86028359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Silano, R. Amaral, V. Neves, Rodolfo Santana, Paulo Cézar, Galvão do Amaral
{"title":"Gastric GIST with 13 kg in Asymptomatic Patient: A Rare Case of Giant GIST and Literature Review","authors":"F. Silano, R. Amaral, V. Neves, Rodolfo Santana, Paulo Cézar, Galvão do Amaral","doi":"10.33696/gastroenterology.3.037","DOIUrl":"https://doi.org/10.33696/gastroenterology.3.037","url":null,"abstract":"Although gastrointestinal stromal tumors, GISTs, are the most common neoplasms arising from the gastrointestinal mesenchyme, they represent less than 1% of all digestive tumors [1]. Its incidence has increased in recent years, probably due to improved diagnostic methods [2]. It is currently known that GIST is the most common sarcoma [3]. It originates from interstitial cells of Cajal and depends on the transcription factor ETV-1. These are neoplasms associated with molecular alterations and some mutations: In more than 75% of cases there is the KIT mutation (CD 117) [3], 10% have mutation in platelet-derived growth factor receptor alpha (PDGFRA) and wild-type GISTs have a mutation in the SDH pathway [3]. There does not seem to be a predilection between the sexes. They affect a wide age range, but in around 75% of cases, it is more common over 50 years of age [4]. Any organ of the digestive tract can be affected by GIST, however more than 50% of cases are seen in the stomach, 25% in the small intestine and a minority in the colon, rectum, retroperitoneum, omentum, among others [5-9]. Its size can vary from millimetric lesions to the so-called giant GISTs, a definition in the literature for those with more than 10 cm in diameter [10].","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"109 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78385297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. Faerber, K. Kuhn, E. Svehlikova, A. Kuchinka-Koch, T. Pieber
{"title":"Oral Lactulose – A Safe and Effective Strategy for the Management of Constipation in Individuals with Impaired Glucose Tolerance and Diabetes","authors":"V. Faerber, K. Kuhn, E. Svehlikova, A. Kuchinka-Koch, T. Pieber","doi":"10.33696/gastroenterology.3.036","DOIUrl":"https://doi.org/10.33696/gastroenterology.3.036","url":null,"abstract":"Valentin Faerber1*, Katharina Stefanie Kuhn2, Eva Svehlikova3, Angelika Kuchinka-Koch4, Thomas R Pieber3 1Department of Medical, Clinical & Regulatory Affairs, Business Unit Parenteral Nutrition, Keto-Analogues and Standard I.V. Fluids, Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany 2Medical Writing, Stuttgart, Germany 3Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz 8036, Austria 4Market Unit Lactulose, Fresenius Kabi Austria GmbH, Linz, Austria *Correspondence should be addressed to Valentin Faerber; Valentin.faerber@fresenius-kabi.com","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73968496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shiv K. Desai, C. Schammel, D. Schammel, A. Devane, D. Steven, Trocha
{"title":"Intraductal Tubular Adenoma: A Case Report and Diagnostic Algorithm for Intraductal Pancreatic Lesions","authors":"Shiv K. Desai, C. Schammel, D. Schammel, A. Devane, D. Steven, Trocha","doi":"10.33696/gastroenterology.3.040","DOIUrl":"https://doi.org/10.33696/gastroenterology.3.040","url":null,"abstract":"A Case Report and Diagnostic Algorithm for Intraductal Abstract Intraductal lesions of the pancreas are an increasingly recognized, radiologically detectable group of entities that require a systematic diagnostic approach to best define management given their variable prognoses. A case of isolated intraductal tubular adenoma (ITA) is reported with a comprehensive literature review; comparison of ITAs with intraductal papillary mucinous neoplasms (IPMNs) and intraductal tubular carcinomas (ITCs) is made with assessment of their distinctive imaging and histological findings and discussion of the evolution of these lesions’ classifications with regards to the established literature. We designed and propose an algorithm for the evaluation of these intraductal lesions to create a systematic approach for the diagnosis and management of such lesions. and histologic characteristics mirrored the aforementioned findings from the MPD; no increased mitotic rate, cytological atypia, or necrosis were identified. IHC indeterminant","PeriodicalId":8277,"journal":{"name":"Archives of Gastroenterology Research","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82659274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}